Article Details

REGAL Trial Receives Green Light to Continue Testing Galinpepimut-S in AML - OncLive

Retrieved on: 2022-12-09 16:48:20

Tags for this article:

Click the tags to see associated articles and topics

REGAL Trial Receives Green Light to Continue Testing Galinpepimut-S in AML - OncLive. View article details on hiswai:

Excerpt

“Following a prespecified review of unblinded data by the IDMC in accordance ... which triggered modifications to the statistical analysis plan, ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up